Summary
Bone tissue is a source of growth factors; among them, insulin-like growth factor I (IGF-I) is probably an important local regulator of bone formation. This study has been carried out in order to assess the effects of natural menopause on plasma concentrations of IGF-I in the first 6 years after the cessation of gonadal function independent of age. We also examined the relationship between plasma IGF-1 levels and bone mineral density (BMD) measured at the lumbar spine (LS), at the ultradistal radius (UDR), and at the junction of the distal and middle thirds of the radius (MR). Sixty-seven healthy nonobese women, aged 45–55, were studied (premenopausal n = 21; postmenopausal n = 46, from 1 to 6 years since menopause). Plasma IGF-I levels were measured by RIA, after acid-ethanol extraction. BMD of the forearm was measured by dual-photon densitometer and BMD of the LS was assessed by quantitative digital radiography. Mean values of IGF-I plasma levels were significantly reduced in postmenopausal women compared to the premenopausal group. Menopausal duration did not influence IGF-I plasma levels in postmenopausal women. We also found a positive correlation between IGF-I levels and BMD measured at MR both in pre- and postmenopausal women, while a correlation with LS and UDR-BMD was found only in fertile subjects. The results show that IGF-I plasma levels decrease immediately after menopause, since significantly lower levels are reached in the first years. The correlations found between plasma IGF-I levels and BMD suggest a possible role of reduced IGF-I in bone loss at particular skeletal sites.
Similar content being viewed by others
References
Raisz LG (1988) Local and systemic factors in the pathogenesis of osteoporosis. N Engl J Med 318:818–828
Canalis E, Mc Carthy T, Centrella M (1988) Growth factors and the regulation of bone remodeling. J Clin Invest 81:277–281
Sara VR, Hall K (1990) Insulin-like growth factors and their binding proteins. Physiol Rev 70:591–614
Canalis E, Mc Carthy T, Centrella M (1988) Isolation and characterization of insulin-like growth factor I (Somatomedin C) from cultures of fetal rat calvariae. Endocrinology 122:22–27
Wong GL, Kotliar D, Schlaeger D, Brandes SJ (1990) IGF-I production by mouse osteoblasts. J Bone Miner Res 5:133–140
Valentin-Opran A, Delmas PD, Chevassieux PM, Chenu C, Saez S, Meunier P (1986) 1,25-Dihydroxyvitamin D3 stimulates the somatomedin C secretion by human bone cells in vitro. J Bone Miner Res Suppl 1:(Abs) 139
Spencer EM, Liu CC, Si ECC, Howard GA (1991) In vivo actions of insulin-like growth factor I (IGF-I) on bone formation and resorption in rats. Bone 12:21–26
Hock JM, Centrella M, Canalis E (1988) Insulin-like growth factor-I has independent effects on bone matrix formation and cell replication. Endocrinology 122:254–260
Mc Carthy T, Centrella M, Canalis E (1989) Regulatory effects of insulin-like growth factors I and II on bone collagen synthesis in rat calvarial cultures. Endocrinology 124:301–309
Canalis E, Lian JB (1988) Effects of bone associated growth factors on DNA, collagen and osteocalcin synthesis in cultured fetal rat calvariae. Bone 9:243–246
Thiebaud D, Ng KW, Findlay DM, Harker M, Martin TJ (1990) Insulinlike growth factor I regulates mRNA levels of osteonectin and pro-a1 (I)-collagen in clonal preosteoblastic calvarial cells. J Bone Miner Res 5:761–767
Zhang RW, Simmons DJ, Crowther RS, Mohan S, Baylink DJ (1991) Contribution of marrow stromal cells to the regulation of osteoblast proliferation in rats: evidence for the involvement of insulin-like growth factors. Bone Miner 13:201–215
Yamamoto H, Sohmiya M, Oka N, Kato Y (1991) Effects of aging and sex on plasma insulin-like growth factor I (IGF-I) levels in normal adults. Acta Endocrinol (Copenh) 124:497–500
Bando H, Zhang C, Takada Y, Yamasaki R, Saito S (1991) Impaired secretion of growth-hormone-releasing hormone, growth hormone and IGF-I in elderly men. Acta Endocrinol (Copenh) 124:31–36
Kelijman M (1991) Age-related alterations of the growth-hormone/insulin-like growth factor I axis. J Am Geriatr Soc 39:295–307
Vermeulen A (1987) Nyctoemeral growth hormone profiles in young and aged men: correlation with somatomedin-C levels. J Clin Endocrinol Metab 64:884–888
Poehlman ET, Copeland KC (1990) Influence of physical activity on insulin-like growth factor I in healthy younger and older man. J Clin Endocrinol Metab 71:1468–1473
Bennett AE, Wahner HW, Riggs L, Hintz RL (1984) Insulin-like growth factors I and II: aging and bone density in women. J Clin Endocrinol Metab 59:701–704
Kelly PJ, Eisman JA, Stuart MC, Pocock NA, Sambrook PN, Gwinn TH (1990) Somatomedin-C, physical fitness, and bone density. J Clin Endocrinol Metab 70:718–723
Dawson-Hughes B, Stern D, Goldman J, Reichlin S (1986) Regulation of growth hormone and somatomedin-C secretion in postmenopausal women: effect of physiological estrogen replacement. J Clin Endocrinol Metab 63:424–432
Ho KY, Evans WS, Blizzard RM, Veldhuis JD, Merriam GR, Samojlik E, Furlanetto R, Rogol AD, Kaiser DL, Thorner MO (1987) Effects of sex and age on the 24-hour profile of growth hormone secretion in man: importance of endogenous estradiol concentrations. J Clin Endocrinol Metab 64:51–57
Franchimont P, Urbain-Choffray D, Lambelin P, Fontaine MA, Frangin G, Reginster JY (1989) Effects of repetitive administration of growth hormone-releasing hormone on growth hormone secretion, insulin-like growth factor I, and bone metabolism in postmenopausal women. Acta Endocrinol (Copenh) 120:121–128
Weissberger AJ, Ho KKY, Lazarus L (1991) Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-h growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women. J Clin Endocrinol Metab 72:374–381
Bellantoni MF, Harman M, Che DE, Blackman MR (1991) Effects of progestin-opposed transdermal estrogen administration on growth hormone and insulin-like growth factor I in post-menopausal women of different ages. J Clin Endocrinol Metab 72:172–178
Hintz RL (1990) Role of growth hormone and insulin-like growth factor binding proteins. Horm Res 33:105–110
Baxter RC (1991) Physiological role of IGF binding proteins. In: Spencer EM (ed) Modern concepts of insulin-like growth factors. Elsevier, New York, pp 371–380
Donahue LR, Hunter SJ, Sherblom AP, Rosen C (1990) Age-related changes in serum insulin-like growth factor binding proteins in women. J Clin Endocrinol Metab 71:575–579
Rosen C, Donahue LR, Hunter S, Holick M, Kavookjian H, Kirschenbaum A, Mohan S, Baylink DJ (1992) The 24/25-KDa serum insulin-like growth factor-binding protein is increased in elderly women with hip and spine fractures. J Clin Endocrinol Metab 74:24–27
Schmid C, Ernst M, Zapf J, Froesch ER (1989) Release of insulin like growth factor carrier proteins by osteoblasts: stimulation by estradiol and growth hormone. Biochem Biophys Res Commun 160:788–794
Martin JL, Baxter RC (1986) Insulin-like growth factor-binding protein from human plasma. Purification and characterization. J Biol Chem 261:8754–8760
Wood WI, Cachianes G, Henzel WJ, Winslow GA, Spencer SA, Hellniss R, Martin JL, Baxter RC (1988) Cloning and expression of the growth hormone-dependent insulin-like growth factor-binding protein. Mol Endocrinol 2:1176–1185
Ernst M, Heath JK, Rodan GA (1989) Estradiol effects on proliferation, messenger ribonucleic acid for collagen and insulin-like growth factor I, and parathyroid hormone-stimulated adenylate cyclase activity in osteoblastic cells from calvariae and long bones. Endocrinology 125:825–833
Bouillon R (1991) Growth hormone and bone. Horm Res 36(Suppl 1):49–55
Diamond T, Nery L, Posen S (1989) Spinal and peripheral bone mineral densities in acromegaly: the effects of excess growth hormone and hypogonadism. Ann Intern Med 111:567–573
Meier DE, Orwoll ES, Jones JM (1984) Marked disparity between trabecular and cortical bone loss with age in healthy men. Ann Intern Med 101:605–612
Ruegsegger P, Durand EP, Dambacher MA (1991) Differential effects of aging and disease on trabecular and compact bone density of the radius. Bone 12:99–105
Parfitt AM (1991) Growth hormone and adult bone remodelling. Clin Endocrinol 35:467–470
Girasole G, Jilka RL, Passeri G, Boswell S, Boder G, Williams DC, Manolagas SC (1992) 17beta-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: a potential mechanism for the antiosteoporotic effect of estrogens. J Clin Invest 89:883–891
Pacifci R, Brown C, Puscheck E, Friedrich E, Slatopolsky E, Maggio D, Mc Cracken R, Avioli LV (1991) Effect of surgical menopause and estrogen replacement on cytokine release from human blood mononuclear cells. Proc Natl Acad Sci USA 88:5134–5138
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Romagnoli, E., Minisola, S., Carnevale, V. et al. Effect of estrogen deficiency on IGF-I plasma levels: Relationship with bone mineral density in perimenopausal women. Calcif Tissue Int 53, 1–6 (1993). https://doi.org/10.1007/BF01352006
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF01352006